Moderna’s announced the publication of an interim analysis showing that the potential COVID-19 vaccine has produced antibodies in an initial safety trial!

$MRNA #vaccines #Moderna #markets #stocks #equity #StockToWatch #StockMarket # #COVIDVACCINE https://t.co/taJs0LK4GA